Barclays Upgrades Myovant Sciences Ltd. (MYOV) to Overweight
Tweet
Share
E-mail
Get Alerts MYOV Hot Sheet
Price: $26.98 --0%
Rating Summary:
4 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
4 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
Barclays analyst Geoff Meacham upgraded Myovant Sciences Ltd. (NYSE: MYOV) from Equalweight to Overweight with a price target of $25.00 (from $22.00).
The analyst upgrades the name on the heels of the firms' bullish women's health survey and NT data catalysts.
For an analyst ratings summary and ratings history on Myovant Sciences Ltd. click here. For more ratings news on Myovant Sciences Ltd. click here.
Shares of Myovant Sciences Ltd. closed at $19.19 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baidu (BIDU) PT Lowered to $150 at Benchmark on Near-Term Margin Concerns
- Viking Holdings (VIK) PT Raised to $121 at UBS Ahead of Q2 Earnings
- Klarna (KLAR) PT Lowered to $15 at BMO Capital
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Hot Upgrades, UpgradesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
